pain during Rocuronium injection in general anesthesia induction.
Conditions
Interventions
Intervention 1: Intervention group 1: group K, 10 mg ketorolac (Exir Iran pharmaceutical company) injection in 2 ml in the left arm and 2 mg of 0.9% Normal Saline simultaneously in the the right arm.
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Elective surgery candidates undergoing general anesthesia ASA class I and II
Exclusion criteria
Exclusion criteria: History of Thrombophlebitis, vascular disease, chronic pain, Diabetes History of burns, and tumors in the hand with the catheter History of addiction or any contraindications for the drugs used in the study Not consenting to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual analog scale pain scores. Timepoint: during and 1 minute after Rocuronium injection. Method of measurement: visual analog scale pain. | — |
Secondary
| Measure | Time frame |
|---|---|
| Mean arterial blood pressure. Timepoint: on entering the operation room, 5 minutes and ten minutes after injection of intervention drugs, at the time of induction and every 10 minutes after induction for 30 minutes. Method of measurement: Sphygmomanometer.;Arterial oxygen saturation. Timepoint: on entering the operation room, 5 minutes and ten minutes after injection of intervention drugs, at the time of induction and every 10 minutes after induction for 30 minutes. Method of measurement: pulse oximetry.;Heart beat. Timepoint: on entering the operation room, 5 minutes and ten minutes after injection of intervention drugs, at the time of induction and every 10 minutes after induction for 30 minutes. Method of measurement: taking Radial pulse for 1 minute. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNazanin Hassannejad
Arak University of Medical Sciences
Outcome results
None listed